JAMES R III GAVIN
CIK 1220966 · President and CEO · last filed 2020-09-15
JAMES R III GAVIN is a President and CEO who has filed 106 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for BAX, was dated Sep 15, 2020. Across all open-market trades the lifetime net is −$5.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $909.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$909.9K
3
106
-$5.33M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BAX | Director | 43,618 | $20.86 | $909.9K | -$5.10M | 68 | 2020-09-15 |
| Baxalta Inc (BXLT) Delisted | Director | 30,747 | — | — | -$226.2K | 4 | 2016-05-12 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Director | 4,580 | — | — | -$10.0K | 29 | 2012-05-24 |
Recent Filings
106 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-09-15 | BAX | Other (J) | — | $0 | EDGAR |
| 2020-08-05 | BAX | Mixed | — | -$719.1K | EDGAR |
| 2020-05-07 | BAX | Grant (A) | +2,197 | $0 | EDGAR |
| 2019-08-20 | BAX | Mixed | — | -$432.9K | EDGAR |
| 2019-07-10 | BAX | Grant (A) | — | $0 | EDGAR |
| 2019-05-15 | BAX | Grant (A) | — | $0 | EDGAR |
| 2019-05-09 | BAX | Grant (A) | +2,412 | $0 | EDGAR |
| 2019-01-16 | BAX | Grant (A) | — | $0 | EDGAR |
| 2018-11-19 | BAX | Grant (A) | — | $0 | EDGAR |
| 2018-08-13 | BAX | Grant (A) | — | $0 | EDGAR |